Shingrix Vaccine
ÃÛÌÒÉçÇø Michigan University's Sindecuse Health Center administers Shingrix, a vaccine to prevent shingles in adults aged 50 years and older. The new vaccine provides more protection than the previous Zostavax vaccine. Patients receive two doses of the vaccine separated by two to six months. The vaccine may be taken by patients experiencing or recovering from immunosuppression.
Shingrix will be administered at the health center for patients over the age of 50. Please note that Medicare Advantage plans do not pay for Shingrix immunizations at Sindecuse Health Center. For more information contact health center at (269) 387-4219.
— Centers for Disease Control and Prevention